FOXP3 is expressed in epithelial tissue of breast, lung and prostate where it acts as a tumor-suppressor gene, as proven by the presence of genetic alteration in FOXP3 in human breast cancer samples [23]. This evidence concerns the gene FOXP3 and breast carcinoma.